114 related articles for article (PubMed ID: 17084439)
1. Desmoglein 3 as a prognostic factor in lung cancer.
Fukuoka J; Dracheva T; Shih JH; Hewitt SM; Fujii T; Kishor A; Mann F; Shilo K; Franks TJ; Travis WD; Jen J
Hum Pathol; 2007 Feb; 38(2):276-83. PubMed ID: 17084439
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
3. HSPA2 is expressed in human tumors and correlates with clinical features in non-small cell lung carcinoma patients.
Scieglinska D; Gogler-Piglowska A; Butkiewicz D; Chekan M; Malusecka E; Harasim J; Habryka A; Krawczyk Z
Anticancer Res; 2014 Jun; 34(6):2833-40. PubMed ID: 24922646
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
[TBL] [Abstract][Full Text] [Related]
5. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
7. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
[TBL] [Abstract][Full Text] [Related]
8. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
[TBL] [Abstract][Full Text] [Related]
9. ADAM8 as a novel serological and histochemical marker for lung cancer.
Ishikawa N; Daigo Y; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
Clin Cancer Res; 2004 Dec; 10(24):8363-70. PubMed ID: 15623614
[TBL] [Abstract][Full Text] [Related]
10. Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.
Haro A; Yano T; Kohno M; Yoshida T; Koga T; Okamoto T; Takenoyama M; Maehara Y
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S509-16. PubMed ID: 23456319
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
[TBL] [Abstract][Full Text] [Related]
12. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.
Masuda K; Takano A; Oshita H; Akiyama H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2011 Dec; 17(24):7712-22. PubMed ID: 22016508
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
14. Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
Agackiran Y; Ozcan A; Akyurek N; Memis L; Findik G; Kaya S
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):350-5. PubMed ID: 22495379
[TBL] [Abstract][Full Text] [Related]
15. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
16. High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer.
Feng J; Zhang X; Zhu H; Wang X; Ni S; Huang J
Am J Clin Pathol; 2012 Aug; 138(2):230-5. PubMed ID: 22904134
[TBL] [Abstract][Full Text] [Related]
17. Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer.
Chen P; Yu J; Knecht J; Chen Q
Cancer Epidemiol; 2013 Apr; 37(2):166-71. PubMed ID: 23312889
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 overexpression in non-small cell lung cancer.
Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
[TBL] [Abstract][Full Text] [Related]
19. High expression of TNFSF13 in tumor cells and fibroblasts is associated with poor prognosis in non-small cell lung cancer.
Qian Z; Qingshan C; Chun J; Huijun Z; Feng L; Qiang W; Qiang X; Min Z
Am J Clin Pathol; 2014 Feb; 141(2):226-33. PubMed ID: 24436270
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
